Discounted Cash Flow (DCF) Analysis Unlevered

enVVeno Medical Corporation (HJLI)

$10.38

-0.21 (-1.98%)
All numbers are in Millions, Currency in USD
Stock DCF: -0.09 | 10.38 | overvalue

Operating Data

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 0.790.420.190.03000000
Revenue (%)
EBITDA -3.18-7.44-6.05-7.230.37-0.05-0.02-0.01-0-0
EBITDA (%)
EBIT -3.33-7.58-6.18-7.63-0.01-0.08-0.03-0.01-0-0
EBIT (%)
Depreciation 0.150.140.130.400.380.030.01000
Depreciation (%)

Balance Sheet Data

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 0.060.082.741.310.010.020.01000
Total Cash (%)
Account Receivables 0.190.040.030.01000000
Account Receivables (%)
Inventories 0.090.050.020000000
Inventories (%)
Accounts Payable 0.541.451.081.2200.010000
Accounts Payable (%)
Capital Expenditure -0.37-0.01-0.01-0.36-0.18-0.01-0-0-0-0
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 10.38
Beta 1.540
Diluted Shares Outstanding 0.86
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 11.097
Total Debt 0
Total Equity 8.91
Total Capital 8.91
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 0.790.420.190.03000000
EBITDA -3.18-7.44-6.05-7.230.37-0.05-0.02-0.01-0-0
EBIT -3.33-7.58-6.18-7.63-0.01-0.08-0.03-0.01-0-0
Tax Rate 39.38%0.00%0.00%0.00%0.00%7.88%7.88%7.88%7.88%7.88%
EBIAT -2.02-7.58-6.18-7.63-0.01-0.08-0.02-0.01-0-0
Depreciation 0.150.140.130.400.380.030.01000
Accounts Receivable -0.1500.03000000
Inventories -0.040.030.02000000
Accounts Payable -0.91-0.370.14-1.220.01-0.01-0-0-0
Capital Expenditure -0.37-0.01-0.01-0.36-0.18-0.01-0-0-0-0
UFCF -2.24-6.35-6.40-7.40-1.02-0.05-0.03-0.01-0-0
WACC
PV UFCF -0.04-0.02-0.01-0-0
SUM PV UFCF -0.08

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 11.10
Free cash flow (t + 1) -0
Terminal Value -0.01
Present Value of Terminal Value -0.01

Intrinsic Value

Enterprise Value -0.08
Net Debt -0.01
Equity Value -0.07
Shares Outstanding 0.86
Equity Value Per Share -0.09